U. B. Schaad
- Microbiology top 0.5%
- Bacterial Infections and Vaccines 14
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 9
- Endocrinology top 5%
- Epidemiology top 5%
- Pneumonia and Respiratory Infections 16
-
- Antibiotics Pharmacokinetics and Efficacy 13
-
- Cystic Fibrosis Research Advances 12
- Inhalation and Respiratory Drug Delivery 5
-
- Pharmaceutical studies and practices 7
-
- Streptococcal Infections and Treatments 4
- Co-authors
- J WedgwoodS. SuterF. A. WaldvogelStephen L. LeibDavid LeppertDaniel DesgrandchampsCaroline GrygarGeorg A. Holländer
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
U. B. Schaad
58 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 118
- Microbiology 508
- Molecular Medicine 321
- Applied Microbiology and Biotechnology 70
- Endocrinology 147
- Epidemiology 967
Countries citing papers authored by U. B. Schaad
This map shows the geographic impact of U. B. Schaad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. B. Schaad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. B. Schaad more than expected).
Fields of papers citing papers by U. B. Schaad
This network shows the impact of papers produced by U. B. Schaad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. B. Schaad. The network helps show where U. B. Schaad may publish in the future.
Co-authorship network
The 25 scholars most cited alongside U. B. Schaad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 16 | |
| 2 | 2015 | 0 | |
| 3 | 2006 | 29 | |
| 4 | 2003 | 24 | |
| 5 | 2000 | 216 | |
| 6 | 1997 | 6 | |
| 7 | 1996 | 1 | |
| 8 | 1994 | 30 | |
| 9 | 1993 | 135 | |
| 10 | 1992 | 41 | |
| 11 | 1992 | 33 | |
| 12 | 1992 | 44 | |
| 13 | 1991 | 68 | |
| 14 | 1991 | 44 | |
| 15 | 1989 | 36 | |
| 16 | 1989 | 82 | |
| 17 | 1988 | 5 | |
| 18 | 1988 | 42 | |
| 19 | 1988 | 22 | |
| 20 | [Antibiotic therapy of bacterial meningitis]. | 1984 | 2 |
About U. B. Schaad
U. B. Schaad is a scholar working on Microbiology, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 59 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (16 papers), Bacterial Infections and Vaccines (14 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Cystic Fibrosis Research Advances (12 papers), Antibiotic Resistance in Bacteria (9 papers), Pharmaceutical studies and practices (7 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Streptococcal Infections and Treatments (4 papers). The work is most often cited by research in Microbiology (508 citations), Molecular Medicine (321 citations) and Applied Microbiology and Biotechnology (70 citations). U. B. Schaad has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include J Wedgwood, S. Suter, F. A. Waldvogel, Stephen L. Leib, David Leppert, Daniel Desgrandchamps, Caroline Grygar, Georg A. Holländer, Karen Miller and K. Stoeckel. Their work appears in journals such as The Lancet, Clinical Infectious Diseases and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.